Published in Infect Immun on December 01, 2000
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 5.91
Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun (1976) 4.59
Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis (1972) 2.56
Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes. J Exp Med (1975) 2.49
Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis (1976) 1.86
Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun (1985) 1.82
Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics (1977) 1.70
Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant. Proc Natl Acad Sci U S A (1978) 1.66
Development of B lymphocytes. I. Cell populations and a critical event during ontogeny. J Immunol (1975) 1.65
Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest (1991) 1.64
Functional heterogeneity of murine lymphoid cells. II. Acquisition of mitogen responsiveness and of theta antigen during the ontogeny of thymocytes and "T" lymphocytes. Cell Immunol (1972) 1.61
Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr (1986) 1.55
The enhancement of the virulence of Candida albicans in mice. J Infect Dis (1952) 1.44
Effect of host age on experimental K virus infection in mice. Infect Immun (1981) 1.42
Ontogeny of the immune response as a basis of childhood disease. J Pediatr (1980) 1.37
Virulence of fungi: correlation of virulence of Blastomyces dermatitidis in vivo with escape from macrophage inhibition of replication in vitro. Infect Immun (1981) 1.25
Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr (1979) 1.24
Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response. J Immunol (1976) 1.22
Changes in suppressor mechanisms during postnatal development in mice. J Exp Med (1978) 1.22
Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 im mice. Infect Immun (1978) 1.21
The disease spectrum of human histoplasmosis. Ann Intern Med (1958) 1.21
Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res (1987) 1.19
Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol (1980) 1.17
Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infect Dis (1990) 1.17
Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol (1994) 1.09
Ontogeny of macrophage-mediated protection against Listeria monocytogenes. Infect Immun (1985) 1.08
Age-dependent resistance of mice to sindbis virus infection: reticuloendothelial role. J Reticuloendothel Soc (1973) 1.06
The gamut of paracoccidioidomycosis. Am J Med (1976) 1.05
Murine model of paracoccidioidomycosis. Production of fatal acute pulmonary or chronic pulmonary and disseminated disease: immunological and pathological observations. J Exp Pathol (1984) 1.04
Characteristics and functional capacities of human cord blood granulocytes and monocytes. Pediatr Res (1984) 1.02
Cellular (T cell) immunity in the human newborn. Pediatrics (1979) 1.01
Phagocyte function in the neonate: selected aspects. Pediatrics (1979) 1.01
Measurement and comparison of the proliferative and antibody response of neonatal, immature and adult murine spleen cells to T-dependent and T-independent antigens. Cell Immunol (1976) 1.01
Susceptibility of mice to acute and persistent measles infection. Infect Immun (1978) 1.00
Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines. Clin Exp Immunol (1987) 1.00
Monocyte function in human neonates. Infect Immun (1978) 0.99
Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol (1984) 0.98
Ontogeny of murine macrophages: functions related to antigen presentation. Infect Immun (1982) 0.98
Peritoneal macrophage response in neonatal mice. J Reticuloendothel Soc (1973) 0.98
Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus. Mycopathologia (1977) 0.97
Ontogeny of macrophage function to release superoxide anion in conventional and germfree mice. Infect Immun (1986) 0.96
Non-T cell nature of the naturally occurring, spleen-associated suppressor cells present in the newborn mouse. Eur J Immunol (1979) 0.96
Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice. J Immunol (1980) 0.95
Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN. Clin Exp Immunol (1986) 0.94
Maturity as a critical determinant of resistance to fungal infections: studies in murine blastomycosis. Infect Immun (1982) 0.94
Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun (1985) 0.94
Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures. Infect Immun (1984) 0.92
Defective oxidative metabolism in newborn neutrophils: discrepancy between superoxide anion and hydroxyl radical generation. Pediatrics (1979) 0.88
Virulent isolates and mutants of Blastomyces in mice: a legacy for studies of pathogenesis. Semin Respir Infect (1997) 0.88
Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect Immun (1983) 0.88
Opsonic activity of cord blood sera against various species of microorganism. Pediatr Res (1985) 0.87
Maturation of B cell differentiation ability and T cell regulatory function during child growth assessed in a Nocardia water soluble mitogen-driven system. J Immunol (1981) 0.87
Antimicrobial defenses in the neonate. Semin Perinatol (1990) 0.87
Protection against pulmonary blastomycosis: adoptive transfer with T lymphocytes, but not serum, from resistant mice. Cell Immunol (1982) 0.86
Oxidative metabolism in cord blood monocytes and monocyte-derived macrophages. Infect Immun (1985) 0.86
Enhancing effect of murine polymorphonuclear neutrophils (PMN) on the multiplication of Blastomyces dermatitidis in vitro and in vivo. Clin Exp Immunol (1983) 0.85
Further studies on suppressor cell activity in the spleen of neonatal mice. Cell Immunol (1979) 0.85
Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates. Cell Immunol (1985) 0.84
Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma. J Immunol (1987) 0.84
Host defenses in the neonate: prospects for enhancement. Semin Perinatol (1985) 0.83
Sex-related immunocompetence of BALB/c mice. I. Study of immunologic responsiveness of neonatal, weanling, and young adult mice. J Immunol (1979) 0.82
Acute pulmonary blastomycosis in children: clinical course and follow-up. Pediatrics (1979) 0.82
Interleukin-2 production in the neonatal mouse. Transplantation (1985) 0.82
Analysis of age-dependent resistance to murine coronavirus JHM infection in mice. Infect Immun (1981) 0.82
Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function: studies with fungal targets. Cell Immunol (1987) 0.82
Comparative mitogenic responses of T-cells and B-cells in spleens of mice of varying age. Immunol Commun (1975) 0.81
Splenic suppressor cells in fetal and newborn mice. Arch Immunol Ther Exp (Warsz) (1978) 0.80
Neutrophil chemiluminescence during the first month of life. Acta Haematol (1980) 0.79
Myeloperoxidase deficiency in neutrophils of neonates. J Pediatr (1988) 0.78
Plasma effects on phagocytic activity and hydrogen peroxide production by polymorphonuclear leukocytes in neonates. Clin Immunol Immunopathol (1997) 0.78
Enhanced killing of Blastomyces dermatitidis by gamma interferon-activated murine peripheral blood polymorphonuclear neutrophils. Int J Immunopharmacol (1989) 0.77
The mononuclear phagocyte system: role in expression of immunocompetence in neonatal and adult life. Pediatrics (1979) 0.76
Neonatal neutrophil dysfunction. Am J Pediatr Hematol Oncol (1989) 0.76
Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatr Res (1988) 0.76
Mononuclear phagocytes in the newborn: their relation to the state of relative immunodeficiency. Am J Pediatr Hematol Oncol (1983) 0.75
Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol (1987) 13.21
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size. Antimicrob Agents Chemother (1976) 8.54
A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci U S A (1988) 7.75
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis (1991) 6.43
Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods. Antimicrob Agents Chemother (1978) 5.94
Direct allelic variation scanning of the yeast genome. Science (1998) 5.90
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) (2000) 4.98
Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis (1983) 4.42
Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med (1976) 3.91
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob Agents Chemother (1982) 3.91
Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother (1982) 3.90
Treatment of invasive aspergillosis with itraconazole. Am J Med (1989) 3.87
Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am Rev Respir Dis (1978) 3.75
Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med (1991) 3.69
Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad Med J (1979) 3.55
Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis (1975) 2.99
Variability of agar dilution-replicator method of yeast susceptibility testing. Antimicrob Agents Chemother (1979) 2.84
Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin. J Infect Dis (1990) 2.66
Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol (1974) 2.64
Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother (1990) 2.49
Genetic characterization of pathogenic Saccharomyces cerevisiae isolates. Genetics (1994) 2.41
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis (1992) 2.41
Analysis of Candida albicans phenotypes from different geographical and anatomical sources. J Clin Microbiol (1983) 2.33
Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med (1982) 2.25
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother (1992) 2.22
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol (1999) 2.15
Treatment of mycoses with itraconazole. Ann N Y Acad Sci (1988) 2.11
Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother (1997) 2.07
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Ketoconazole blocks testosterone synthesis. Arch Intern Med (1982) 2.01
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest (1991) 2.00
Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies. Am J Med (1976) 1.93
Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med (1996) 1.91
Distribution of a corticosteroid-binding protein in Candida and other fungal genera. J Gen Microbiol (1983) 1.86
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother (1988) 1.85
Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun (1985) 1.82
Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis. Antimicrob Agents Chemother (1990) 1.81
Postexposure varicella management of nonimmune personnel: an alternative approach. Infect Control Hosp Epidemiol (1994) 1.77
Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis (1993) 1.76
Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med (1989) 1.76
Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med (1973) 1.73
Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. Proc Natl Acad Sci U S A (1972) 1.73
A five-year study of needlestick injuries: significant reduction associated with communication, education, and convenient placement of sharps containers. Infect Control Hosp Epidemiol (1992) 1.72
Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography. Antimicrob Agents Chemother (1991) 1.72
Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae. Infect Immun (1994) 1.72
Viral infections in man associated with acquired immunological deficiency states. Fed Proc (1972) 1.70
In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect Immun (1977) 1.69
Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis (1994) 1.69
Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun (1984) 1.65
Interferon, antibody, and other host factors in herpes zoster. J Clin Invest (1972) 1.64
Comparison of fluconazole and ketoconazole in experimental murine blastomycosis. Rev Infect Dis (1990) 1.61
Pathogen factors and host factors in murine pulmonary blastomycosis. Mycopathologia (1982) 1.61
Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother (1991) 1.61
Emerging pathogens. Med Mycol (2000) 1.59
Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med (1991) 1.58
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis (1992) 1.58
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med (2000) 1.58
Treatment of fungal meningitis with miconazole. Arch Intern Med (1977) 1.57
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrob Agents Chemother (1989) 1.53
Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 1.53
Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole. Rev Infect Dis (1987) 1.53
Bioassays for itraconazole blood levels: an interlaboratory collaborative study. J Antimicrob Chemother (1999) 1.52
Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis. J Med Vet Mycol (1994) 1.52
Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion. Antimicrob Agents Chemother (1992) 1.52
Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice. Sabouraudia (1982) 1.51
High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med (1984) 1.51
Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis. Antimicrob Agents Chemother (1992) 1.50
Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis. Antimicrob Agents Chemother (1991) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis. Proc Natl Acad Sci U S A (1983) 1.47
Standardized management of patients and employees exposed to pertussis. Infect Control Hosp Epidemiol (1998) 1.46
Epidemiologic study by DNA typing of a Candida albicans outbreak in heroin addicts. J Clin Microbiol (1991) 1.44
Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. Am J Med (1990) 1.43
Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods. J Clin Microbiol (1997) 1.42
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother (1994) 1.41
Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am J Epidemiol (1967) 1.41
Laboratory evaluation of an outbreak of nocardiosis in immunocompromised hosts. Am J Med (1981) 1.40
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis (1991) 1.40
Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J Clin Microbiol (1991) 1.38
Susceptibility differences of inbred strains of mice to blastomycosis. Infect Immun (1981) 1.37
Comparison of various techniques for determining viability of Paracoccidioides brasiliensis yeast-form cells. J Clin Microbiol (1982) 1.35
Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agents Chemother (1987) 1.34
Dermal sensitivity to different doses of spherulin and coccidioidin. Chest (1974) 1.33
Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J Antimicrob Chemother (1992) 1.33
Deep infections from Petriellidium boydii treated with miconazole. JAMA (1979) 1.32
In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J Immunol (1988) 1.32
Macrophages and fungi: in vitro effects of method of macrophage induction, activation by different stimuli, and soluble factors on Blastomyces. J Reticuloendothel Soc (1980) 1.31
Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J Clin Microbiol (1998) 1.30
Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med (1995) 1.29
Complement fixation antibody test for human nocardiosis. J Clin Microbiol (1978) 1.27